Author

Jack Syage

LATIGLUTENASE – AN EFFECTIVE ORAL THERAPY IN DEVELOPMENT FOR THE TREATMENT OF CELIAC DISEASE: EXPLORING THE BENEFITS AND CHALLENGES OF ADMINISTERING AND MEASURING GLUTEN IN A CLINICAL TRIAL SETTING
LATIGLUTENASE – AN EFFECTIVE ORAL THERAPY IN DEVELOPMENT FOR THE TREATMENT OF CELIAC DISEASE: EXPLORING THE BENEFITS AND CHALLENGES OF ADMINISTERING AND MEASURING GLUTEN IN A CLINICAL TRIAL SETTING

Jack Syage  et al.

CELIACSHIELD (TM) GLUTEN CHALLENGE STUDY – GLUTEN IMMUNOGENIC PEPTIDE MEASUREMENTS IN URINE VALIDATE THE LATIGLUTENASE MECHANISM OF ACTION AND PROVIDE A MEASURE OF COMPLIANCE IN A CLINICAL TRIAL SETTING
CELIACSHIELD (TM) GLUTEN CHALLENGE STUDY – GLUTEN IMMUNOGENIC PEPTIDE MEASUREMENTS IN URINE VALIDATE THE LATIGLUTENASE MECHANISM OF ACTION AND PROVIDE A MEASURE OF COMPLIANCE IN A CLINICAL TRIAL SETTING

Jack Syage  et al.

Item 1 - 2 / 2
1